AGC Biologics has successfully manufactured more than 200 biological projects for pre-clinical studies through commercial approvals. Our teams of scientists at our cell and viral vector gene therapy sites have more than two decades of manufacturing experience.
Our seven state-of-the-art facilities across the globe offer innovative design, expanding capacity, technological ingenuity, and teams dedicated to strict biopharmaceutical regulations required for cGMP operations.
